SHR-3792
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 26, 2025
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=150 | Recruiting | Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Solid Tumor
1 to 1
Of
1
Go to page
1